CDC Distributing Monkeypox Vaccines Nationwide While Raising Monkeypox Travel Alert to Level 2
On June 6, 2022, the U.S. Centers for Disease Control and Prevention (CDC) raised its monkeypox travel alert to Level 2, warning Americans to “Practice Enhanced Precautions.”1 The agency stated that monkeypox cases have been rising in at least 29 countries, with 1,019 infections reported to date. Currently, the United States has confirmed 31 cases […]
FDA Panel Recommends EUA for Novavax COVID-19 Vaccine
Despite concerns about the risk of developing myocarditis (inflammation of the heart muscle) and pericarditis (inflammation of the lining of the heart) following vaccination with Novavax’s experimental NVX-CoV2373 (also known as “Nuvaxovid” and “Covovax”) COVID-19 vaccine, the U.S. Food and Drug Administration’s (FDA) Vaccines and Related Biological Products Advisory Committee (VRBPAC) voted on June 6, […]
FDA Flags Risk of Myocarditis in Novavax COVID Vaccine
Novavax, one of the worst performers on Wall Street, and that is after an FDA warning on its COVID vaccine. Year to date, down 68 percent. Of course, that coming as a result of the FDA out with their analysis from Novavax’s data that they submitted for the emergency use filing for the meeting coming […]
Guillain-Barré Syndrome Linked to COVID-19 Shots
A study by the University College London showed that serious Guillain-Barré syndrome (GBS), which can result in temporary or permanent paralysis, is a “small but significant” risk associated with AstraZeneca/Oxford University’s AZD1222 (or “Vaxzevria”) vaccine. Of the 996 cases of GBS that were recorded in the United Kingdoms’ National Immunisation Management System database between January […]
More Monkeypox Cases Identified as Roche is Ready With PCR Tests
There had been 584 confirmed cases of monkeypox virus in 26 countries as of May 31, 2022.1 The largest outbreak is in the United Kingdom where 190 people are infected with the virus, followed by Spain with 132 people infected, and Portugal with 100 people infected. Before this year, monkeypox in humans was thought to […]
Pfizer, Moderna Apply for EUA for COVID Shots for Infants, FDA to Decide Quickly
On June 1, 2022, Pfizer and BioNTech submitted an application to the U.S. Food and Drug Administration (FDA) for an Emergency Use Authorization (EUA) to distribute their messenger RNA (mRNA) BNT162b2 (also known as “Comirnaty”) COVID-19 biologic for children as young as six months to five years old. The application is for a three-dose regimen, […]